Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorDUBOIS, Véronique
dc.contributor.authorDE BARBEYRAC, Bertille
dc.contributor.authorROGUES, Anne-Marie
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorARPIN, Corinne
IDREF: 093324626
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorCOULANGE, Laure
dc.contributor.authorANDRE, Catherine
dc.contributor.authorM'ZALI, Fatima
dc.contributor.authorMEGRAUD, Francis
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorQUENTIN, Claudine
dc.date.accessioned2024-10-19T09:01:34Z
dc.date.available2024-10-19T09:01:34Z
dc.date.issued2010-07-01
dc.identifier.issn1460-2091en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/202591
dc.description.abstractEnTo investigate the high prevalence of extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli (4%, 10/250 consecutive isolates) recovered during a 5 month period in the maternity ward of the University Hospital of Bordeaux, France. beta-Lactam resistance transfer was analysed by conjugation and transformation. ESBLs were characterized by isoelectric focusing, PCR amplification and sequencing. The relatedness of the strains was examined by PFGE and phylogenetic group determination. Plasmids were characterized by incompatibility group and restriction analysis. Ten ESBL-producing E. coli were isolated from urinary or genital samples of eight mothers and from gastric fluids of two newborns of carrier mothers. The patients were hospitalized in five different units of the maternity ward. Transconjugants, obtained for 7 of the 10 strains, and wild-type strains exhibited various antibiotypes. Different CTX-M enzymes were characterized: CTX-M-1 (n = 4); CTX-M-14 (n = 3); CTX-M-32 (n = 2); and CTX-M-28 (n = 1). The strains recovered from two mothers and their respective babies were identical. All the other strains were epidemiologically unrelated. Furthermore, various plasmids were identified. Environmental samples from the common echographic and sampling rooms did not reveal the presence of ESBL-producing enterobacteria. The data argue against the occurrence of a nosocomial outbreak and support the hypothesis of an importation of community-acquired ESBL-producing strains into the hospital through colonized/infected patients. At present, not only patients transferred from other hospitals or long-term care facilities are at risk of carrying ESBL-producing enterobacteria on hospital admission, but also community patients.
dc.language.isoENen_US
dc.subject.enAdult
dc.subject.enAnti-Bacterial Agents
dc.subject.enBacterial Typing Techniques
dc.subject.enCommunity-Acquired Infections
dc.subject.enDNA Fingerprinting
dc.subject.enElectrophoresis
dc.subject.enGel
dc.subject.enPulsed-Field
dc.subject.enEnvironmental Microbiology
dc.subject.enEscherichia coli
dc.subject.enEscherichia coli Infections
dc.subject.enEscherichia coli Proteins
dc.subject.enFemale
dc.subject.enFrance
dc.subject.enGenotype
dc.subject.enHospitals
dc.subject.enMaternity
dc.subject.enHospitals
dc.subject.enUniversity
dc.subject.enHumans
dc.subject.enInfant
dc.subject.enNewborn
dc.subject.enInfectious Disease Transmission
dc.subject.enVertical
dc.subject.enMicrobial Sensitivity Tests
dc.subject.enPlasmids
dc.subject.enPregnancy
dc.subject.enbeta-Lactamases
dc.subject.enbeta-Lactams
dc.title.enCTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
dc.title.alternativeJ Antimicrob Chemotheren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/jac/dkq153en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologieen_US
dc.identifier.pubmed20466850en_US
bordeaux.journalJournal of Antimicrobial Chemotherapyen_US
bordeaux.page1368-71en_US
bordeaux.volume65en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue7en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Antimicrobial%20Chemotherapy&rft.date=2010-07-01&rft.volume=65&rft.issue=7&rft.spage=1368-71&rft.epage=1368-71&rft.eissn=1460-2091&rft.issn=1460-2091&rft.au=DUBOIS,%20V%C3%A9ronique&DE%20BARBEYRAC,%20Bertille&ROGUES,%20Anne-Marie&ARPIN,%20Corinne&COULANGE,%20Laure&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée